| Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E–Deficient mice MA Ostos, M Conconi, L Vergnes, N Baroukh, J Ribalta, J Girona, ... Arteriosclerosis, thrombosis, and vascular biology 21 (6), 1023-1028, 2001 | 180 | 2001 |
| Fatty acid binding protein 4 is increased in metabolic syndrome and with thiazolidinedione treatment in diabetic patients A Cabre, I Lazaro, J Girona, JM Manzanares, F Marimon, N Plana, ... Atherosclerosis 195 (1), e150-e158, 2007 | 178 | 2007 |
| Evidence of hypolipemiant and antioxidant properties of argan oil derived from the argan tree (Argania spinosa) A Drissi, J Girona, M Cherki, G Godàs, A Derouiche, M El Messal, R Saile, ... Clinical Nutrition 23 (5), 1159-1166, 2004 | 176 | 2004 |
| Simvastatin decreases aldehyde production derived from lipoprotein oxidation J Girona, AE La Ville, R Solà, N Plana, L Masana The American journal of cardiology 83 (6), 846-851, 1999 | 169 | 1999 |
| Retinol‐binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes A Cabre, I Lazaro, J Girona, J Manzanares, F Marimon, N Plana, M Heras, ... Journal of internal medicine 262 (4), 496-503, 2007 | 155 | 2007 |
| Plasma fatty acid binding protein 4 is associated with atherogenic dyslipidemia in diabetes A Cabré, I Lázaro, J Girona, JM Manzanares, F Marimón, N Plana, ... Journal of lipid research 49 (8), 1746-1751, 2008 | 125 | 2008 |
| Exogenous FABP4 increases breast cancer cell proliferation and activates the expression of fatty acid transport proteins S Guaita‐Esteruelas, A Bosquet, P Saavedra, J Gumà, J Girona, ... Molecular carcinogenesis 56 (1), 208-217, 2017 | 115 | 2017 |
| Role of the fatty acid-binding protein 4 in heart failure and cardiovascular R Rodriguez-Calvo, J Girona, JM Alegret, A Bosquet, D Ibarretxe, ... Journal of Endocrinology 233, R173-R184, 2017 | 114 | 2017 |
| Oleic acid rich diet protects against the oxidative modification of high density lipoprotein R Solà, AE La Ville, JL Richard, C Motta, MT Bargalló, J Girona, L Masana, ... Free Radical Biology and Medicine 22 (6), 1037-1045, 1997 | 103 | 1997 |
| Antioxidant vitamins and lipid peroxidation in patients with rheumatoid arthritis: association with inflammatory markers. S Paredes, J Girona, E Hurt-Camejo, JC Vallvé, S Olivé, M Heras, ... The Journal of Rheumatology 29 (11), 2271-2277, 2002 | 98 | 2002 |
| Unsaturated fatty acids and their oxidation products stimulate CD36 gene expression in human macrophages JC Vallvé, K Uliaque, J Girona, A Cabré, J Ribalta, M Heras, L Masana Atherosclerosis 164 (1), 45-56, 2002 | 95 | 2002 |
| Effects of soluble fiber (Plantago ovatahusk) on plasma lipids, lipoproteins, and apolipoproteins in men with ischemic heart disease R Sola, G Godas, J Ribalta, JC Vallvé, J Girona, A Anguera, MA Ostos, ... The American journal of clinical nutrition 85 (4), 1157-1163, 2007 | 85 | 2007 |
| HDL triglycerides: a new marker of metabolic and cardiovascular risk J Girona, N Amigó, D Ibarretxe, N Plana, C Rodríguez-Borjabad, M Heras, ... International Journal of Molecular Sciences 20 (13), 3151, 2019 | 82 | 2019 |
| Apolipoprotein and apolipoprotein receptor genes, blood lipids and disease J Ribalta, JC Vallvé, J Girona, L Masana Current Opinion in Clinical Nutrition & Metabolic Care 6 (2), 177-187, 2003 | 82 | 2003 |
| Fatty acid-binding protein 4 impairs the insulin-dependent nitric oxide pathway in vascular endothelial cells G Aragonès, P Saavedra, M Heras, A Cabré, J Girona, L Masana Cardiovascular diabetology 11, 1-8, 2012 | 80 | 2012 |
| Clinical and pathophysiological evidence supporting the safety of extremely low LDL levels—The zero-LDL hypothesis L Masana, J Girona, D Ibarretxe, R Rodríguez-Calvo, R Rosales, ... Journal of clinical lipidology 12 (2), 292-299. e3, 2018 | 76 | 2018 |
| FABP4 induces vascular smooth muscle cell proliferation and migration through a MAPK-dependent pathway J Girona, R Rosales, N Plana, P Saavedra, L Masana, JC Vallvé PLoS One 8 (11), e81914, 2013 | 70 | 2013 |
| Fatty acid-binding protein 4 is associated with endothelial dysfunction in patients with type 2 diabetes G Aragonès, R Ferré, I Lázaro, A Cabré, N Plana, J Merino, M Heras, ... Atherosclerosis 213 (1), 329-331, 2010 | 70 | 2010 |
| Plasma fatty acid-binding protein 4 increases with renal dysfunction in type 2 diabetic patients without microalbuminuria A Cabre, I Lazaro, J Girona, JM Manzanares, F Marimon, N Plana, ... Clinical chemistry 54 (1), 181-187, 2008 | 69 | 2008 |
| Oxidized to non-oxidized lipoprotein ratios are associated with arteriosclerosis and the metabolic syndrome in diabetic patients J Girona, JM Manzanares, F Marimón, A Cabré, M Heras, M Guardiola, ... Nutrition, Metabolism and Cardiovascular Diseases 18 (5), 380-387, 2008 | 67 | 2008 |
